Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mammalian dendritic cell chemokine reagents

Mammalian dendritic cell chemokine reagents

US Patent 6812004 · Granted Nov 2, 2004

Estimated economic value: $148,273,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzoimidazole derivatives as anticancer agents2025
Methods and apparatus for identifying alternative splicing events2024
Agents that engage antigen-presenting cells through dendritic cell asialoglycopr2024
Fusion proteins comprising an anti-CD40 antibody and cancer antigens2023
Breast cancer splice variants2023
Compositions and methods for the systemic treatment of arthritis2022
Benzoimidazole derivatives as anticancer agents2022
Nucleic acids encoding anti-CD40 antibodies2022
Antibodies directed against ICOS and uses thereof2021
CD73 blocking agents2021
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides2021
Fusion proteins comprising an anti-CD40 antibody and cancer antigens2021